These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1190 related items for PubMed ID: 17289287

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury.
    Elias AE, Carlos RC, Smith EA, Frechtling D, George B, Maly P, Sundgren PC.
    Acad Radiol; 2011 Sep; 18(9):1101-8. PubMed ID: 21820634
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
    Server A, Josefsen R, Kulle B, Maehlen J, Schellhorn T, Gadmar Ø, Kumar T, Haakonsen M, Langberg CW, Nakstad PH.
    Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy.
    Laprie A, Pirzkall A, Haas-Kogan DA, Cha S, Banerjee A, Le TP, Lu Y, Nelson S, McKnight TR.
    Int J Radiat Oncol Biol Phys; 2005 May 01; 62(1):20-31. PubMed ID: 15850898
    [Abstract] [Full Text] [Related]

  • 8. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
    Lichy MP, Bachert P, Hamprecht F, Weber MA, Debus J, Schulz-Ertner D, Schlemmer HP, Kauczor HU.
    Rofo; 2006 Jun 01; 178(6):627-33. PubMed ID: 16703499
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In the assessment of supratentorial glioma grade: the combined role of multivoxel proton MR spectroscopy and diffusion tensor imaging.
    Zou QG, Xu HB, Liu F, Guo W, Kong XC, Wu Y.
    Clin Radiol; 2011 Oct 01; 66(10):953-60. PubMed ID: 21663899
    [Abstract] [Full Text] [Related]

  • 11. Central nervous system lymphoma characterization by diffusion-weighted imaging and MR spectroscopy.
    Zacharia TT, Law M, Naidich TP, Leeds NE.
    J Neuroimaging; 2008 Oct 01; 18(4):411-7. PubMed ID: 18494774
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of 3 Tesla proton MR spectroscopy, MR perfusion and MR diffusion for distinguishing glioma recurrence from posttreatment effects.
    Fink JR, Carr RB, Matsusue E, Iyer RS, Rockhill JK, Haynor DR, Maravilla KR.
    J Magn Reson Imaging; 2012 Jan 01; 35(1):56-63. PubMed ID: 22002882
    [Abstract] [Full Text] [Related]

  • 14. Proton magnetic resonance spectroscopic imaging to differentiate between nonneoplastic lesions and brain tumors in children.
    Hourani R, Horská A, Albayram S, Brant LJ, Melhem E, Cohen KJ, Burger PC, Weingart JD, Carson B, Wharam MD, Barker PB.
    J Magn Reson Imaging; 2006 Feb 01; 23(2):99-107. PubMed ID: 16374884
    [Abstract] [Full Text] [Related]

  • 15. Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema.
    Server A, Kulle B, Maehlen J, Josefsen R, Schellhorn T, Kumar T, Langberg CW, Nakstad PH.
    Acta Radiol; 2009 Jul 01; 50(6):682-9. PubMed ID: 19449234
    [Abstract] [Full Text] [Related]

  • 16. Diagnostic value of proton magnetic resonance spectroscopy in the noninvasive grading of solid gliomas: comparison of maximum and mean choline values.
    Senft C, Hattingen E, Pilatus U, Franz K, Schänzer A, Lanfermann H, Seifert V, Gasser T.
    Neurosurgery; 2009 Nov 01; 65(5):908-13; discussion 913. PubMed ID: 19834403
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Quantitative assessment of gliomas by proton magnetic resonance spectroscopy.
    Oshiro S, Tsugu H, Komatsu F, Abe H, Onishi H, Ohmura T, Iwaasa M, Sakamoto S, Fukushima T.
    Anticancer Res; 2007 Nov 01; 27(6A):3757-63. PubMed ID: 17970039
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI.
    Yang D, Korogi Y, Sugahara T, Kitajima M, Shigematsu Y, Liang L, Ushio Y, Takahashi M.
    Neuroradiology; 2002 Aug 01; 44(8):656-66. PubMed ID: 12185543
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 60.